BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2311446)

  • 1. Pharmacokinetics and cerebrospinal fluid concentration of nafcillin in pediatric patients undergoing cerebrospinal fluid shunt placement.
    Nahata MC; Fan-Havard P; Kosnik EJ; Bartkowski MH; Barson WJ
    Chemotherapy; 1990; 36(2):98-102. PubMed ID: 2311446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and cerebrospinal fluid (CSF) concentrations of vancomycin in pediatric patients undergoing CSF shunt placement.
    Fan-Havard P; Nahata MC; Bartkowski MH; Barson WJ; Kosnik EJ
    Chemotherapy; 1990; 36(2):103-8. PubMed ID: 2311439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, cerebrospinal fluid concentration, and safety of intravenous rifampin in pediatric patients undergoing shunt placements.
    Nahata MC; Fan-Havard P; Barson WJ; Bartkowski HM; Kosnik EJ
    Eur J Clin Pharmacol; 1990; 38(5):515-7. PubMed ID: 2379538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetrance of nafcillin into human ventricular fluid: correlation with ventricular pleocytosis and glucose levels.
    Yogev R; Schultz WE; Rosenman SB
    Antimicrob Agents Chemother; 1981 Apr; 19(4):545-8. PubMed ID: 7247377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic prophylaxis in ventricular shunt surgery. II. Antibiotic concentrations in cerebrospinal fluid.
    McCullough DC; Kane JG; Harleman G; Wells M
    Childs Brain; 1980; 7(4):190-4. PubMed ID: 7438840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin disposition and penetration into ventricular fluid of the central nervous system following intravenous therapy in patients with cerebrospinal devices.
    Jorgenson L; Reiter PD; Freeman JE; Winston KR; Fish D; McBride LA; Handler MH
    Pediatr Neurosurg; 2007; 43(6):449-55. PubMed ID: 17992031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and cerebrospinal fluid concentrations of cefixime in infants and young children.
    Nahata MC; Kohlbrenner VM; Barson WJ
    Chemotherapy; 1993; 39(1):1-5. PubMed ID: 8444056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftriaxone kinetics and cerebrospinal fluid penetration in infants and children with meningitis.
    Nahata MC; Durrell DE; Barson WJ
    Chemotherapy; 1986; 32(2):89-94. PubMed ID: 3698727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin pharmacokinetics in hydrocephalic shunt prophylaxis and relationship to ventricular volume.
    LeRoux P; Howard MA; Winn HR
    Surg Neurol; 1990 Dec; 34(6):366-72. PubMed ID: 2244299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid shunt placement in the pediatric population: a model of hospitalization cost.
    Lam SK; Srinivasan VM; Luerssen TG; Pan IW
    Neurosurg Focus; 2014 Nov; 37(5):E5. PubMed ID: 25363433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nafcillin concentration in cerebrospinal fluid during treatment of staphylococcal infections.
    Kane JG; Parker RH; Jordan GW; Hoeprich PD
    Ann Intern Med; 1977 Sep; 87(3):309-11. PubMed ID: 900676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraventricular nafcillin-induced seizures in a neonate.
    Brozanski BS; Scher MS; Albright AL
    Pediatr Neurol; 1988; 4(3):188-90. PubMed ID: 3242521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of nafcillin in patients with cirrhosis and extrahepatic biliary obstruction.
    Marshall JP; Salt WB; Elam RO; Wilkinson GR; Schenker S
    Gastroenterology; 1977 Dec; 73(6):1388-92. PubMed ID: 913979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of cerebrospinal fluid output through external ventricular drainage in one hundred infants and children: correlation with cerebrospinal fluid production.
    Yasuda T; Tomita T; McLone DG; Donovan M
    Pediatr Neurosurg; 2002 Jan; 36(1):22-8. PubMed ID: 11818742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and prevention of infections of cerebrospinal fluid shunts.
    Fan-Havard P; Nahata MC
    Clin Pharm; 1987 Nov; 6(11):866-80. PubMed ID: 3315400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shunting in hydrocephalus due to tuberculous meningitis. Cases presenting with high cerebrospinal fluid proteins in pediatric age.
    Kilincoglu BF; Dalkilic T; Dincbal MN; Aydin Y
    J Neurosurg Sci; 2009 Jun; 53(2):49-53. PubMed ID: 19546843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related amrinone pharmacokinetics in a pediatric population.
    Allen-Webb EM; Ross MP; Pappas JB; McGough EC; Banner W
    Crit Care Med; 1994 Jun; 22(6):1016-24. PubMed ID: 8205809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters.
    Eymann R; Chehab S; Strowitzki M; Steudel WI; Kiefer M
    J Neurosurg Pediatr; 2008 Jun; 1(6):444-50. PubMed ID: 18518694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of probenecid on nafcillin disposition.
    Waller ES; Sharanevych MA; Yakatan GJ
    J Clin Pharmacol; 1982 Oct; 22(10):482-9. PubMed ID: 7174857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefadroxil kinetics and dynamics in a pediatric patient with acute osteomyelitis.
    Nahata MC; Jackson DS; Powell DA
    Chemotherapy; 1990; 36(6):392-5. PubMed ID: 2292202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.